Clinical trial
A Multi-Center, Retrospective Review of Implant-Based Post Mastectomy Breast Reconstruction Utilizing SurgiMend® Collagen Matrix in Prepectoral and Submuscular Surgical Approaches
NCT05182177 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Retrospective Review of Implant-Based Post Mastectomy Breast Reconstruction Utilizing SurgiMend® Collagen Matrix in Prepectoral and Submuscular Surgical Approaches
- Lead sponsor
- Integra LifeSciences Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2022
- Completion date
- December 31, 2024
- Enrollment
- 84 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
reconstructive surgical procedures